However, Gln-supplemented animals exhibited an increase in phosphorylated GSK3b, suggesting an inactivation of GSK3b that has been recently shown to favor glutaminolysis and thus glutamine utilization as a carbon source in lung cancer cells [56]. Here, GSK3B is linked to lung carcinoma.